The role of chromatin modifiers in normal and malignant hematopoiesis
about
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapiesKDM1 class flavin-dependent protein lysine demethylasesEpigenetic regulation of epithelial-mesenchymal transitionExpression atlas of the multivalent epigenetic regulator Brpf1 and its requirement for survival of mouse embryos.Deficiency of the chromatin regulator BRPF1 causes abnormal brain development.MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development.Perspectives and future directions for epigenetics in hematology.Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia.Panobinostat: a review of trial results and future prospects in multiple myeloma.Crosstalk between histone modifications indicates that inhibition of arginine methyltransferase CARM1 activity reverses HIV latency.SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.The chromatin-associated Sin3B protein is required for hematopoietic stem cell functions in mice.Tracking hematopoietic precursor division ex vivo in real time.Repression of Primitive Erythroid Program Is Critical for the Initiation of Multi-Lineage Hematopoiesis in Mouse Development.Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia.
P2860
Q26744080-B01026DC-E402-4088-BAD4-B88DD8AB67A2Q28084876-59CFEC1E-A1ED-40C7-875E-4159873BFF76Q33764436-7DAD3E50-B5DF-42B1-81D2-0956D3CFBEC1Q33784606-4FAA05C4-EBEA-4211-A454-C2AF769A4C35Q34457162-8245585B-5FC8-4773-84DD-BC5625C88AB9Q35634908-07A2C429-6A4C-40D7-A156-0D4175C90898Q36962664-61C1C8F3-A824-4781-8066-23524A782729Q38129336-C9F8768C-EC69-41F9-BF2B-7E07E3A6371AQ38269612-443912F6-5C4D-4768-957A-25F85F111017Q40150928-A917E0F0-9926-42DE-8B99-B137293F6819Q43685807-F9CAB400-C2DE-4BD8-A9DE-786422F9997FQ48251042-F8C85ECE-6523-463F-A8C4-E5F80DC0169AQ48505870-020B388F-E2C8-46EA-B63E-08D77B66F55BQ50481045-12EBCD37-FE90-4C65-A8E8-D5E9C28C9A49Q51142663-3C2DAE74-06C1-4E58-9D0C-943D8ADCB159
P2860
The role of chromatin modifiers in normal and malignant hematopoiesis
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The role of chromatin modifiers in normal and malignant hematopoiesis
@en
type
label
The role of chromatin modifiers in normal and malignant hematopoiesis
@en
prefLabel
The role of chromatin modifiers in normal and malignant hematopoiesis
@en
P2860
P1433
P1476
The role of chromatin modifiers in normal and malignant hematopoiesis
@en
P2093
Jill S Butler
P2860
P304
P356
10.1182/BLOOD-2012-10-451237
P407
P50
P577
2013-01-02T00:00:00Z